The 6 analysts offering 12-month price forecasts for Decibel Therapeutics Inc have a median target of 22.00, with a high estimate of 30.00 and a low estimate of 14.00. The median estimate represents a +391.07% increase from the last price of 4.48.
The current consensus among 6 polled investment analysts is to Buy stock in Decibel Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.48
Reporting Date Mar 28
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.